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Cell fusion mediated by Epstein–Barr virus requires three conserved glycoproteins, gB and gHgL, but activation is cell type specific. B cell
fusion requires interaction between MHC class II and a fourth virus glycoprotein, gp42, which complexes non-covalently with gHgL. Epithelial
cell fusion requires interaction between gHgL and a novel epithelial cell coreceptor and is blocked by excess gp42. We show here that gp42
interacts directly with gH and that point mutations in the region of gH recognized by an antibody that differentially inhibits epithelial and B cell
fusion significantly impact both the core fusion machinery and cell-specific events. Substitution of alanine for glycine at residue 594 completely
abrogates fusion with either B cells or epithelial cells. Substitution of alanine for glutamic acid at residue 595 reduces fusion with epithelial cells,
greatly enhances fusion with B cells and allows low levels of B cell fusion even in the absence of gL.
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Although the process by which any herpesvirus mediates
fusion with the cell membrane is poorly understood, there is an
emerging consensus that, for each, it involves a temporal
cascade of events that requires participation of three conserved
glycoproteins, gB and gHgL (Spear and Longnecker, 2003).
This fusion apparatus, sometimes referred to as the core fusion
machinery, can be triggered into an active state either as a result
of an interaction of one of the proteins with a cell surface
molecule that functions as an entry mediator, or as a result of a
similar interaction mediated by an additional accessory protein.
Epstein–Barr virus (EBV) fusion can be triggered in either way,
depending on the cell type involved. Fusion with B lympho-
cytes is triggered by an interaction with the major histocompat-
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doi:10.1016/j.virol.2007.01.025virus glycoprotein, gp42, which forms a non-covalently linked
complex with gHgL (Li et al., 1997; Wang and Hutt-Fletcher,
1998). Fusion with epithelial cells is triggered by a direct
interaction of gHgL and an as yet unidentified gHgL receptor,
gHgLR (Borza et al., 2004; Wang et al., 1998). Whether this
latter interaction involves residues of gH or a domain
comprising residues of both gH and gL is unclear since, like
all gH homologs, EBV gH is incompletely processed and
transported in the absence of gL (Li et al., 1995; Yaswen et al.,
1993). The EBV virion contains both gHgL and gHgLgp42
complexes as they are mutually exclusive for B cell and
epithelial cell entry. Only three part gHgLgp42 complexes can
mediate B cell infection and only two part complexes that lack
gp42 can mediate epithelial cell infection (Wang et al., 1998).
The presence of gp42 blocks the essential interaction with
gHgLR (Borza et al., 2004).
We recently hypothesized that if the core fusion machinery
of EBV for both B cells and epithelial cells is comprised of gB
and gHgL and differs only in the way it is triggered, it might be
possible to distinguish regions of gHgL that are capable of
supporting fusion with an epithelial cell but not a B cell, or vice
versa. We made a series of two amino acid insertions between
Fig. 2. Surface expression of point mutants measured by flow cytometry. AGS
cells were transfected with plasmids expressing gB and gL together with wild-
type gH or mutant gH and stained with Mab anti-Flag and fluorescein-
conjugated sheep anti-mouse antibody. The mean level of fluorescence for cells
transfected with gB, gL and wild-type gH and stained with fluorescein-
conjugated sheep anti-mouse antibody alone was subtracted from the mean
levels of cells transfected with wild-type or mutant gH. The remaining value for
wild-type gH was set at 100 and the remaining values for each mutant were
expressed as a percent of this value. Vertical lines equal the standard deviation of
3 experiments.
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vity of a monoclonal antibody (Mab) that blocked epithelial cell
but not B cell entry. Of these, mutant M10, in which a serine
and an arginine residue were inserted after residue 592, and
mutant M11, in which the same amino acids were inserted after
residue 607, had opposing properties. In a cell-based fusion
assay M10 could mediate fusion with an epithelial cell but not
a B cell whereas M11 mediated no fusion with an epithelial
cell but mediated considerably more fusion with a B cell than
could the wild-type protein (Wu et al., 2005). To explore
further the importance of this region of gH to fusion with either
cell type we made a series of more conservative alanine
substitutions around residues 592 and 607. We report here that
individual residues between 592 and 597 significantly impact
both the core fusion machinery and cell-specific events and
that some changes in gH can at least ameliorate its need for
coexpression with gL.
Results
Expression of proteins with alanine substitutions
A total of nine point mutants were made in which alanine
was substituted for residues between positions 592 and 607 of a
Flag-tagged gH cloned in the pCAGGS vector (Fig. 1). The
substitutions clustered around the sites of insertions previously
used to generate insertion mutants M10 and M11 (Wu et al.,
2005). When transfected into AGS epithelial cells each point
mutant expressed a protein that could be recognized in indirect
immunofluorescence assays of permeabilized cells by Mab anti-
Flag and by three Mabs to gH or gHgL, CL59, CL40 and E1D1
(data not shown). None of the EBV-specific Mabs react with
EBV proteins in Western blots of native gels (unpublished) and
it is assumed that each recognizes a conformational epitope.
Surface expression of each mutant was determined by flow
cytometry with Mab anti-Flag and compared with that of theFig. 1. Linear map of EBV gH indicating the positions of the predicted signal sequenc
acids surrounding the insertion mutants M10 and M11 and the positions of the alanwild-type pCAGGS-Flag-gH. All mutants were expressed at or
close to wild-type levels at the cell surface (Fig. 2).
Comparison of the ability of wild-type gH and point mutants to
mediate cell-to-cell fusion of epithelial cells
Each of the point mutants was next compared with
pCAGGS-Flag-gH for the ability to mediate cell-to-cell fusion
when transfected into AGS epithelial cells together with
pCAGGS-gL and pCAGGS-gB. pCAGGS-Flag-gH had pre-
viously been shown to support fusion at a level equivalent to a
wild-type untagged version of gH in the same vector (Wu et al.,
2005). The original insertion after residue 607 which had beene, the predicted transmembrane domain and the Flag tag. The sequence of amino
ine substitutions are indicated.
Fig. 4. Fusion of Daudi B cells supported by point mutants and measured as
relative luciferase activity. CHO-K1 cells were transfected with plasmids
expressing gB and gL together with wild-type gH, mutant gH or empty vector
and a plasmid expressing luciferase under control of the T7 promoter.
Transfected cells were overlayed with Daudi 29 cells expressing T7 RNA
polymerase. Luciferase activity in the presence of empty vector was subtracted
from activity in the presence of wild-type or mutant gH. The remaining value for
wild-type gH was set at 100 and luciferase activity in the presence of each
mutant was expressed as a percentage of this value. Vertical lines indicate the
standard deviation of 8 experiments.
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with epithelial cells. All but one of the point mutants clustered
around this site, however, now mediated wild-type or very close
to wild-type levels of fusion. Only mutant K610A was slightly
impaired mediating fusion at about 80% of wild-type levels
(Fig. 3). The original insertion after residue 592 which had been
made in M10 had produced a protein that was better able to
mediate epithelial cell fusion, though still not at wild-type
levels. Of the point mutants around this site P596A and R597A
now mediated fusion at wild-type levels and fusion mediated by
V592Awas reduced to 80% of this. However, E595A mediated
only 60% of the level of fusion mediated by wild-type Flag gH
and G594A mediated essentially no fusion at all.
Comparison of the ability of wild-type gH and point mutants to
mediate cell-to-cell fusion with target B cells
A similar analysis was done of the ability of point mutants to
mediate fusion with B cells. Plasmids expressing EBV proteins
together with a plasmid expressing the luciferase gene under
control of a T7 promoter were transfected into CHO-K1 cells,
which, unlike AGS cells, do not fuse with each other (McShane
and Longnecker, 2004). The transfected cells were overlayed
with Daudi cells expressing the T7 polymerase and fusion was
measured in terms of an increase in luciferase activity. Of the
point mutants clustered around the original mutant M11, which
had mediated greater than wild-type levels of B cell fusion, two,
T608A and K610A, now behaved as wild-type protein (Fig. 4).
Two, Q609A and R607A, both of which had mediated wild-type
levels of epithelial cell fusion, had reduced ability to mediate B
cell fusion. Q609Awas at 80% and R607Awas at 60% of wild-
type levels. The point mutants clustered around the site of the
insertion mutant M10, which had been poorly fusogenic for B
cells, showed greater divergence. Mutant G594A was just as
unable to support B cell fusion as it had been to support fusion ofFig. 3. Fusion of AGS cells supported by point mutants. AGS cells were
transfected with plasmids expressing gB and gL together with wild-type gH,
mutant gH or empty vector. After 24 h, cells were stained with Mab CL55 to gB
and fusion events were counted by fluorescence microscopy. Numbers of cells
containing four or more nuclei were considered as having undergone fusion and
the percent of cells that had undergone fusion with each mutant is expressed as a
percentage of those that had undergone fusion with wild-type gH. In the absence
of gH no fusion events were seen. Vertical lines equal the standard deviation of 6
experiments.epithelial cells. Mutant V592A, which had mediated epithelial
cell fusion at 80% of wild-type levels, mediated only 60% of
wild-type fusion for B cells. Mutant R597A, which had been
able to mediate wild-type levels of fusion with epithelial cells,
mediated B cell fusion at less than 40% of wild-type levels. In
contrast, mutant E595A, which, despite its wild-type expression
levels, had mediated only 60% of wild-type levels of fusion of
epithelial cells mediated fusion with B cells at levels more than
five times those of wild-type gH.
Complex formation by point mutants
Point mutant G594A, which mediated very little fusion with
epithelial cells and no fusion at all with B cells, reacted with the
Mab E1D1, which only recognizes gH that is complexed with
gL (Li et al., 1995) (Wu and Hutt-Fletcher, unpublished).
However, it remained possible that its inability to mediate B cell
fusion reflected an inability to complex with gp42. To examine
this possibility the point mutant was reconstructed in pTM1-
EBV gH for higher levels of expression. Cells were transfected
with wild-type or mutated pTM1-Flag gH together with pTM1
gL and pTM1 gp42, radiolabeled and immunoprecipitated with
Mab F-2-1 to gp42. Both gH constructs (the only protein of the
gHgLgp42 complex that contains methionine residues for
labeling beside the start residue) could be immunoprecipitated
with F-2-1, confirming that the mutant retained the ability to
form a three part gHgLgp42 complex (Fig. 5). The association
with gL was also reconfirmed by immunoprecipitation with an
antibody to gL.
E595A, in contrast to G594A, had a significantly enhanced
ability to mediate B cell fusion. The ability of E595A to
mediate complex formation was thus also examined more
closely by immunoprecipitation with antibodies to gL and gp42.
Fig. 5. Interaction of wild-type gH and G495Awith gL and gp42. SDS–PAGE
analysis of proteins immunoprecipitated by antibody to gp42, antibody to gL or
antibody to gH from CV1 cells labeled with [35S] methionine and transfected as
indicated with pTM1-EBV gH, pTM1-EBV gL and pTM1-EBV gp42, pTM1-
EBV gL and pTM1-EBV gp42, pTM1-EBV G594A, pTM1-EBV gL and
pTM1-EBV gp42, pTM1 gL and pTM1 empty vector (vect), pTM1 gL and
pTM1-EBV G594A or pTM1 alone. The band indicated with an arrow is gH.
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pected interaction with gL (Fig. 6). Previous work with disrupted
virus had suggested that incorporation of gp42 into a gHgLgp42
complex might result from an interaction with gL (Li et al.,
1995), although such an interaction had not proven possible to
confirm when the two proteins were expressed together in
isolation (unpublished). In the course of this new analysis,Fig. 6. Complex formation by wild-type gH and E595A. SDS–PAGE analysis of
proteins immunoprecipitated by antibody to gH, antibody to gL or antibody to
gp42 from CV1 cells labeled with [35S] methionine and transfected as indicated
with pTM1-EBV gH, pTM1-EBV gL and pTM1-EBV gp42, pTM1-EBV gH
and pTM1-EBV gp42, pTM1-EBV E595A, pTM1-EBV gL and pTM1-EBV
gp42 or pTM1-EBV E595A and pTM1-EBV gp42. The band indicated with an
arrow is gH.however, we found that gp42 interacted directly with either wild-
type gH or E595A in the absence of gL.
Surface expression of gp42 in the presence of gH and E595A
The finding that gp42 interacts directly with gH suggested
that one possible explanation for the enhanced ability of E595A
to mediated B cell fusion might be that its interaction differed in
a way that resulted in expression of higher levels of gp42 at the
cell surface. Previous work had suggested that transport of gp42
occurs independently of gH (Li et al., 1995), but this had been
determined on a qualitative and not a quantitative basis. A Mab
antibody to gp42 was therefore used to make a flow cytometric
analysis of the effects of gH and E595A on the absolute levels
of expression of gp42 at the cell surface. Expression of gp42
with gB, gL and E595A was actually slightly lower in than in
the presence of gB, gL and wild-type gH (Fig 7). Absence of gH
reduced gp42 expression further. Absence of gL, which would
be expected to significantly inhibit transport of gH to the cell
surface, had a similar effect.
Surface expression of gH and E595A and fusion mediated in
the absence of gL
When previous analyses of gH expression at the cell surface
in the absence of gL had been performed no Mabs specific for
gH had been available, and the gH constructs had not been
tagged. The conclusion that transport to the cell surface was
interrupted had been based on observations that gH expressed
alone does not carry the endoglycosidase H-resistant N-linked
sugars that are characteristic of processing of native gH in the
Golgi apparatus (Yaswen et al., 1993) and that iodination of cellFig. 7. Effect of wild-type gH, E595A and gL on surface expression of gp42
measured by flow cytometry. AGS cells were transfected with plasmids
expressing gB and gp42 together with combinations of gL, gH, E595A or empty
vector (vect) as indicated and stained with Mab to gp42 and fluorescein-
conjugated sheep anti-mouse antibody. The mean level of fluorescence for cells
transfected with gB, gL gH and gp42 and stained with fluorescein-conjugated
sheep anti-mouse antibody alone was subtracted from the values obtained for
each combination. The remaining value for expression of gp42 with gB, gL and
wild-type gH was set at 100 and the values for each of the other combinations
were expressed as a percent of this value. Vertical lines indicate the standard
deviation of 3 experiments.
Fig. 8. Surface expression of wild-type gH and E595A in the absence of gL and
the ability to mediate fusion of Daudi B cells. Black bars: AGS cells were
transfected with combinations of plasmids expressing gH or E595A, gB, gp42
and gL or empty vector (vect) as indicated, stained with Mab anti-Flag and
fluorescein-conjugated sheep anti-mouse antibody and analyzed by flow
cytometry. The mean level of fluorescence for cells transfected with gB, gL
gH and gp42 and stained with fluorescein-conjugated sheep anti-mouse
antibody alone was subtracted from the values obtained for each combination.
The remaining value for cells transfected with plasmids expressing gH, gB, gp42
and gL was set at 100 and values for other combinations were expressed as a
percent of this value. Vertical lines equal the standard deviation of 3 experiments.
Grey bars: CHO-K1 cells were transfected with a plasmid expressing luciferase
under control of the T7 promoter and the indicated combinations of plasmids
expressing gB, gL, gp42, gH and E595A. Transfected cells were overlayed with
Daudi 29 cells expressing T7 RNA polymerase. Luciferase activity in the
presence of gB, gL, gp42 and empty vector was subtracted from activity in the
presence of gH or E595A. The remaining value for gB, gL, gp42 and gH was set
at 100 and luciferase activity in the presence of other combinationswas expressed
as a percentage of this value. Vertical lines indicate the standard deviation of 4
experiments.
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in the presence of gL (Li et al., 1995; Yaswen et al., 1993). Since
our gH constructs were now Flag-tagged, we also reevaluated
cell surface expression of gH as well by flow cytometry using
the Mab anti-Flag. Although only very small amounts of both
wild-type gH and E595A could be detected on the surface of the
cell in the absence of gL the signal was, for both, greater than
that seen in the absence of primary antibody (Fig. 8).
Since small amounts of both E595A and wild-type gH could
be seen at the cell surface in the absence of gL and since B cell
fusion supported by E595A was significantly higher than that
supported by wild-type gH, we also looked to see if any B cell
fusion could be mediated by E595A, gp42 and gB in the
absence of gL. When compared to wild-type gH, E595A could
mediate a modest but detectable amount of fusion in the absence
of gL (Fig. 8). Although the variability was high in repeated
experiments, the difference from wild-type gH was significant
(p 0.005). No similar fusion was seen in the absence of both gL
and gp42 and no similar fusion could be detected with epithelial
cells (not shown).
Discussion
The amino terminus of gH has been implicated as being
critical to its role in support of cell fusion. Potentially alphahelical residues 377–397 of the gH homolog of herpes simplex
virus have been proposed to represent an internal fusion peptide
and similar motifs are found in equivalent positions in other
herpesviruses (Gianni et al., 2005a). Residues that are part of a
heptad repeat sequence just downstream of this peptide are also
essential to fusion (Gianni et al., 2005b). Peptides correspond-
ing to a putative coiled-coil domain in human cytomegalovirus
gH between residues 108 and 128 inhibit membrane fusion.
Mutations in residues 52–79 of EBV gH which are also
predicted, although perhaps less robustly, to be part of a coil-
coiled domain, impact fusion with both B cells and epithelial
cells (Omerovic et al., 2005). However, residues close to the
transmembrane domain of herpes simplex virus gH have also
been shown to be essential (Galdiero et al., 1997) and our work
is consistent with this.
The original insertion mutants M10 and M11 had reciprocal
effects on B cell and epithelial cell fusion despite the fact that
they were only 15 amino acids apart. This suggested that these
sequences were in some way important to triggering fusion both
via HLA class II and gHgLR. Since a soluble form of gp42 that
binds to gHgL in trans also blocks the interaction of gHgL and
gHgLR, this did not seem unreasonable. The single alanine
substitutions made here are consistent with the previous obser-
vations in that they show that even closely adjacent residues
can differentially affect the behavior of the protein. However,
they did not entirely recapitulate the effects of the original
insertions.
Single amino acid substitutions in the sequence around site
of the M11 insertion had relatively little impact on fusion with
either cell type, but the two that had modest but significant
effects, R607A and K610A, reciprocally affected B cell and
epithelial cell fusion. Adjacent single amino acid substitutions
around the site of insertion of M10 had more pronounced
effects. Alanine substitutions at residues 592 and 597 (V592A
and R597A) both significantly impacted, though did not
abrogate B cell fusion and had little or no effect on fusion
with an epithelial cell. These mutations were in line with the
original M10, which only mediated epithelial cell fusion.
Substitution of an alanine for a glycine residue at position 594,
however, essentially abrogated fusion with both cell types.
Whether this means that this residue is important for a “core”
event downstream of fusion or rather that it blocks triggering
either via HLA class II or gHgLR cannot currently be
determined. The protein at least retained the ability to interact
with gp42, although it may have been impaired in translating a
signal from the gp42 HLA class II interaction downstream. The
substitution of alanine for glutamic acid at the immediately
adjacent residue 595 produced a phenotype similar to that of the
original M10 in its ability to mediate moderate levels of
epithelial cell fusion but differed dramatically in its acquisition
not merely of the ability to mediate B cell fusion but to mediate
it at levels significantly higher than the wild-type protein.
Further exploration of the phenotype of the E595A mutant
led to the previously unrecognized finding that gp42 can
interact directly with gH in the absence of gL. We could,
however, find no evidence for a substantial change in the ability
of E595A to increase the levels of gp42 at the cell surface. This
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either by omitting gL and impairing its transport or by omitting
gH itself from the transfection mix, did reduce the surface levels
of gp42 and implied that at least a portion of gp42 is either
transported to or stabilized at the surface as a result of complex
formation. It was a surprise to find that a very small but
detectable amount of gH could be expressed at the cell surface
in the absence of gL and that the small amount of E595A at the
surface of the cell in the absence of gL could mediate detectable
cell fusion. It did, however, suggest that the E595A mutation
may produce a protein with a conformation least in part similar
to that supported by coexpression of gL and that it perhaps has
an enhanced ability to transmit or amplify an otherwise weak
triggering signal from gp42.
Although there is general consensus that the three conserved
homologs, gB, gH and gL make up the core fusion machinery of
herpesviruses the order in which they are triggered into an
active state is generally less clear and it has remained uncertain
as to whether the fusion event itself involves one or more than
one of the three. Peptides corresponding to predicted alpha
helical coiled-coil domains in the gB and gH homologs of
human cytomegalovirus can independently block virus entry,
but these domains do not appear to function in an identical
manner as coiled coil domains found in class I fusion proteins
and inhibition presumably could reflect either the need for
interaction between the two proteins or the involvement of both
in the events proximal to fusion (Lopper and Compton, 2004).
The interaction of glycoprotein gD with one of several entry
mediators triggers fusion of herpes simplex virus and recent
studies have suggested that this is followed by sequential
interaction of gD, gB and then gHgL (Gianni et al., 2006). The
order in which EBV proteins act may be different, however. A
mutated form of EBV gB is able to mediate fusion in the
absence of gHgL, suggesting that it is the final player in the
process (McShane and Longnecker, 2004). The fact that gHgL
are directly involved in triggering of fusion with epithelial cells
might suggest that they function upstream of gB. The work
done here provides no kinetic data, but the observation that
gp42 directly interacts with gH and that the E595A mutant can,
together with gB, mediate at least small amounts of fusion in the
absence of gL, is consistent with the suggestion that, for B cells
at least, it is to gH that the initial triggering signal is transmitted.
Materials and methods
Cells
CV-1 monkey kidney cells were grown in Dulbecco's
modified Eagle's medium. AGS, a human gastric carcinoma
cell line and Chinese hamster ovary (CHO-K1) cells were
grown in Ham's F12 medium. Daudi 29 cells (a gift of Richard
Longnecker, Northwestern University), B cells that stably
express T7 RNA polymerase from the pOS2 vector (Whetter et
al., 1994), were grown in RPMI medium. All culture media
were obtained from Gibco-BRL Life Technologies (Grand
Island NY) and supplemented with 10% heat inactivated fetal
bovine serum.Antibodies
Antibodies used were monoclonal antibodies (Mabs) E1D1
to gHgL, CL59 and CL40 to gH, CL55 to gB, F-2-1 to gp42 (Li
et al., 1995) and M2 (Sigma-Aldrich, St. Louis, MO) to the Flag
epitope. A rabbit antibody, anti-gL, made to a peptide
corresponding to residues 125 to 137 of gL was also used. All
non-commercial antibodies were affinity purified on protein A-
agarose.
Virus
Stocks of recombinant vaccinia virus expressing the T7
RNA polymerase (vvT7) (a gift of William Britt, University of
Alabama, Birmingham) were grown in CV-1 cells infected
at a multiplicity of infection of 0.01 and harvested by freeze–
thawing and sonication of cells.
Plasmids
Plasmids pTM1-EBV gH and pTM1-EBV gL and pTM1-
gp42 (Li et al., 1995) were made by cloning PCR amplified
sequences into the pTM1 vector (Moss et al., 1990), which
contains a T7 promoter, the encephalomyocarditis virus cap-
independent translation signal, a multiple cloning site and a T7
transcriptional terminator. Translation initiates at the NcoI site in
the multiple cloning region. In pTM1-EBV gH, this site is lost as
a result of blunt end cloning. Plasmids pCAGGS-gH pCAGGS-
gL, pCAGGS-gB and pCAGGS-gp42 (Wu et al., 2005) were
made by cloning PCR amplified sequences into the pCAGGS/
MCS vector (a gift of Martin Muggeridge, LSUHSC) for
expression under control of the β-actin promoter in cooperation
with the HCMV-IE enhancer (Niwa et al., 1991). A Flag-tagged
version of pCAGGS-gH, pCAGGS-Flag-gH (Wu et al., 2005),
was made by insertion of an 8 amino acid Flag epitope between
residues 22 and 23 of the EBV gH sequence, 4 residues after the
predicted cleavage site of the putative signal sequence. Point
mutations in pCAGGS-Flag-gH were made using the Quick-
change II protocol (Stratagene, La Jolla, CA) in a 1.6-kb BglII–
PvuII fragment of gH encompassing sequences coding for
residues 500 to 629 that had been cloned into the 2.5-kb pSP72
vector (Promega, Madison, WI) as previously described (Wu et
al., 2005). The mutated BglII–PvuII fragments were cloned
back into pCAGGS-Flag-EBVgH for assay of fusion activity or
into pTM1-EBV gH for biochemical analysis. The desired
mutation was confirmed by sequencing of the fragments after
return to pCAGGS-EBV Flag-gH.
Transfection–infection protocol
CV-1 cells were grown to 90% confluency in 100-mm-
diameter Petri dishes and infected with vvT7 at a multiplicity of
infection of 5. Thirty minutes later, the inoculum was removed,
and the cells were washed twice in medium without serum and
transfected with pTM1 plasmids. Ten micrograms of DNAwas
mixed with 30 μl of Lipofectamine (Gibco/BRL) made to a total
volume of 2.5 ml with serum-free medium.
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For internal staining, slides bearing air-dried acetone-fixed
cells were incubated at 37 °C for 30 min in a humidified
atmosphere with Mabs, washed three times with phosphate-
buffered saline for 5 min each, reincubated for 30 min with the
appropriate dilution of fluorescein isothiocyanate (FITC)-
conjugated sheep anti-mouse immunoglobulin (ICN/Cappel,
Irvine, CA), washed three times and mounted in Mounting
Medium (Kirkegaard Perry Laboratories, Gaithersburg, MD).
For surface staining, unfixed cells were sequentially incubated
with Mabs and FITC-conjugated anti-mouse immunoglobulin.
Cells were washed three times between incubations and three
times before mounting in Mounting Medium.
Levels of cell surface expression
The levels of expression of wild-type and mutant gH
constructs at the cell surface were measured by flow cytometric
analysis of AGS cells transfected with pCAGGS-Flag-gH or gH
mutants and pCAGGS-gL. DNA (3.2 μg) was mixed with 4 μl
Target transfectin F2 and 12 μl Target peptide enhancer
(Targeting Systems, Santee, CA) in high glucose DMEM
media. Twenty-four hours later, transfected cells were washed
with ice-cold phosphate-buffered saline containing 2% fetal
bovine serum and serially reacted with MAbM2 (anti-Flag) and
phycoerythrin-conjugated anti-mouse immunoglobulin (Jack-
son ImmunoResearch Laboratories, West Grove, PA) with
washing between each step.
AGS cell–cell fusion assay
AGS cells were seeded in two-well chamber slides and were
transfected at 70–80% confluency for 4 h with 0.25 μg
pCAGGS-Flag-gH or 0.25 μg mutated pCAGGS-Flag-gH
together with 0.25 μg pCAGGS-gL and 0.6 μg pCAGGS-gB.
Plasmids were mixed with 1 μl Target transfectin F2 and 2 μl
Target peptide enhancer in high glucose DMEM media.
Twenty-four-hour post-transfection cells were fixed with ice-
cold acetone and stained with Mab to gB. Cells expressing gB
and containing four or more nuclei were considered to have
undergone fusion and were recorded as one fusion event. The
extent of fusion was calculated as the number of fusion events
as a percentage of the total number cells expressing gB. No
fusion was seen in cells that did not stain with Mab to gB.
Epithelial cell–B cell fusion assay
CHO-K1 cells were seeded in 6-well plates and were
transfected at 70–80% confluency for 4 h with mutant 0.8 μg
pCAGGS-Flag-gH or mutated pCAGGS-Flag-gH together with
0.8 μg gL, 1.4 μg pCAGGS-gB and 1.2 μg pCAGGSgp42 as
well as 0.8 μg pST7-Luc containing the T7 promoter upstream
of the luciferase gene (Ferrer et al., 1999) (a gift of Martin
Muggeridge). Each well of transfected cells was then overlayed
with two million Daudi 29 cells that expressed T7 RNA
polymerase. Twenty-four hours later, cells were washed twicewith phosphate-buffered saline and lysed with 500 μl Passive
Lysis Buffer (Promega). Luciferase substrate (100 μl) was
added to 20 μl supernatant of lysate. Luminosity readings were
obtained by using a TD-20/20 luminometer (Promega).
Radiolabeling and immunoprecipitation
CV-1 cells were been infected with vvT7 and transfected
with pTM1 plasmids were labeled biosynthetically with
100 μCi of Pro-Mix (70% [35S]methionine, 30% [35S]cysteine)
and 300 μCi of [35S]cysteine (>1,000 Ci/mmol; Amersham
Biosciences, Arlington IL) per dish (approximately 107 cells) as
previously described (Li et al., 1995). Labeled cells were
solubilized in radioimmunoprecipitation buffer (50 mM Tris–
HCl, pH 7.2, 0.15 M NaCl, 1% Triton X-100, 1% sodium
deoxycholate, 0.1% sodium dodecyl sulfate, 0.1 mM phenyl-
methyl-sulfonylfluoride and 100 U of Aprotinin per ml) and
immunoprecipitated with antibody and protein A-Sepharose
CL4B (Sigma). Immunoprecipitated proteins were washed,
dissociated by boiling for 2 min in sample buffer with 2-
mercaptoethanol and analyzed by sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS–PAGE) in 10%
polyacrylamide cross-linked with 0.28% N,N′-diallyltartardia-
mide followed by fluorography.
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